Picture of Sequana Medical NV logo

SEQUA — Sequana Medical NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Sequana Medical Announces First Patient Enrolled In RED DESERT

Jan 7 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN RED
DESERT –
REPEATED DOSE ALFAPUMP® DSR STUDY FOR TREATMENT OF
DIURETIC-RESISTANT HEART FAILURE PATIENTS
    * STUDY AIMS TO EVALUATE SAFETY OF ALFAPUMP DSR IN PATIENTS
WITH
HEART FAILURE
    * WE LOOK FORWARD TO REPORTING INITIAL INTERIM RESULTS IN Q2
2020
AND PRESENTING FINAL RESULTS IN Q3 2020

Source text for Eikon:  ID:nGNXbBBZK2 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Sequana Medical NV

See all news